Stable transgene expression in mice generated from retrovirally transduced embryonic stem cells

Molecular Therapy

Volumn 15, Issue 3, 2007, Pages 560-565

  Hamanaka, Sanae ^a   Nabekura, Tsukasa ^a   Otsu, Makoto ^b   Yoshida, Hisahiro ^c   Nagata, Michio ^a   Usui, Joichi ^b   Takahashi, Satoru ^a   Nagasawa, Toshiro ^a   Nakauchi, Hiromitsu ^b   Onodera, Masafumi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; RETROVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; EMBRYONIC STEM CELL; GENE DUPLICATION; GENE EXPRESSION REGULATION; GENETIC CODE; GENETIC STABILITY; GENETIC TRANSDUCTION; HEART MUSCLE CELL; HEMATOPOIETIC CELL; INTESTINE; LEUKOCYTE; LONG TERMINAL REPEAT; MOUSE; NERVE CELL; NONHUMAN; PROGENY; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROVIRUS; SARCOMA VIRUS; SUSPENSION CELL CULTURE; TRANSGENE; TRANSGENIC ANIMAL; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS STRAIN; VIRUS TRANSMISSION;

ANIMALS; CHIMERA; EMBRYO, MAMMALIAN; EMBRYONIC STEM CELLS; GENE EXPRESSION; GENES, REPORTER; GENETIC VECTORS; MICE; MICE, INBRED C57BL; MULTIGENE FAMILY; RETROVIRIDAE; STEM CELL TRANSPLANTATION; TRANSGENES;

ANIMALIA; MURINAE; MUS; MUS MUSCULUS; MYELOPROLIFERATIVE SARCOMA VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 33847183914     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300063     Document Type: Article

References (35)

1. Verma, IM and Weitzman, MD (2005). Gene therapy: Twenty-first century medicine. Annu Rev Biochem 74: 711-738.
2. Jaenisch, R (1976). Germ line integration and Mendelian transmission of the exogenous Moloney leukemia virus. Proc Natl Acad Sci USA 73: 1260-1264.
3. Robertson, E, Bradley, A, Kuehn, M and Evans, M (1986). Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature 323: 445-448.
4. Jahner, D et al. (1982). De novo methylation and expression of retroviral genomes during mouse embryogenesis. Nature 298: 623-628.
5. Flanagan, JR, Krieg, AM, Max, EE and Khan, AS (1989). Negative control region at the 5′ end of murine leukemia virus long terminal repeats. Mol Cell Biol 9: 739-746.
6. Swindle, CS, Kim, HG and Klug, CA (2004). Mutation of CpGs in the murine stem cell virus retroviral vector long terminal repeat represses silencing in embryonic stem cells. J Biol Chem 279: 34-41.
7. Franz, T, Hilberg, F, Seliger, B, Stocking, C and Ostertag, W (1986). Retroviral mutants efficiently expressed in embryonal carcinoma cells. Proc Natl Acad Sci USA 83: 3292-3296.
8. Grez, M, Akgun, E, Hilberg, F and Ostertag, W (1990). Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells. Proc Natl Acad Sci USA 87: 9202-9206.
9. Pannell, D et al (2000). Retrovirus vector silencing is de novo methylase independent and marked by a repressive histone code. EMBO J 19: 5884-5894.
10. Cherry, SR, Biniszkiewicz, D, Van, PL, Baltimore, D and Jaenisch, R (2000). Retroviral expression in embryonic stem cells and hematopoietic stem cells. Mol Cell Biol 20: 7419-7426.
11. Laker, C et al. (1998). Host cis-mediated extinction of a retrovirus permissive for expression in embryonal stem cells during differentiation. J Virol 72: 339-348.
12. Loh, TP, Sievert, LL and Scott, RW (1990). Evidence for a stem cell-specific repressor of Moloney murine leukemia virus expression in embryonal carcinoma cells. Mol Cell Biol 10: 4045-4057.
13. Haas, DL et al. (2003). The Moloney murine leukemia virus repressor binding site represses expression in murine and human hematopoietic stem cells. J Virol 77: 9439-9450.
14. Hawley, RG, Lieu, FH, Fong, AZ and Hawley, TS (1994). Versatile retroviral vectors for potential use in gene therapy. Gene Ther 1: 136-138.
15. Nabekura, T, Otsu, M, Nagasawa, T, Nakauchi, H and Onodera, M (2006). Potent vaccine therapy with dendritic cells genetically modified by the gene-silencing-resistant retroviral vector GCDNsap. Mol Ther 13: 301-309.
16. Yamada, M, Onodera, M, Mizuno, Y and Mochizuki, H (2004). Neurogenesis in olfactory bulb identified by retroviral labeling in normal and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated adult mice. Neuroscience 124: 173-181.
17. Suzuki, A et al. (2002). Clonal identification and characterization of self-renewing pluripotent stem cells in the developing liver. J Cell Biol 56: 173-184.
18. Ory, DS, Neugeboren, BA and Mulligan, RC (1996). A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci USA 93: 11400-11406.
19. Onodera, M et al. (1998). Development of improved adenosine deaminase retroviral vectors. J Virol 72: 1769-1774.
20. Halene, S, Wang, L, Cooper, RM, Bockstoce, DC, Robbins, PB and Kohn, DB (1999). Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector. Blood 94: 3349-3357.
21. Suzuki, A et al. (2002). Feasibility of ex vivo gene therapy for neurological disorders using the new retroviral vector GCDNsap packaged in the vesicular stomatitis virus G protein. J Neurochem 82: 953-960.
22. Doetschman, TC, Eistetter, H, Katz, M, Schmidt, W and Kemler, R (1985). The in vitro development of blastocyst-derived embryonic stem cell lines: Formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 87: 27-45.
23. Joyner, AL (1993). Gene Targeting: A Practical Approach. Oxford University Press: Oxford.
24. Yoshida, H, Kunisada, T, Kusakabe, M, Nishikawa, S and Nishikawa, S-I (1996). Distinct stages of melanocyte differentiation revealed by analysis of nonuniform pigmentation patterns. Development 122: 1207-1214.
25. Schmidt, M et al. (2002). Polyclonal long-term repopulating stem cell clones in a primate model. Blood 100: 2737-2743.
26. Kaneko, S, Onodera, M, Fujiki, Y, Nagasawa, T and Nakauchi, H (2001). Simplified retroviral vector gcsap with murine stem cell virus long terminal repeat allows high and continued expression of enhanced green fluorescent protein by human hematopoietic progenitors engrafted in nonobese diabetic/severe combined immunodeficient mice. Hum Gene Ther 12: 35-44.
27. Yamauchi, M, Freitag, B, Khan, C, Berwin, B and Barklis, E (1995). Stem cell factor binding to retrovirus primer binding site silencers. J Virol 69: 1142-1149.
28. Pfeifer, A, Ikawa, M, Dayn, Y and Verma, IM (2002). Transgenesis by lentiviral vectors: Lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc Natl Acad Sci USA 99: 2140-2145.
29. Lois, C, Hong, EJ, Pease, S, Brown, EJ and Baltimore, D (2002). Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295: 868-872.
30. Gaiano, N, Allende, M, Amsterdam, A, Kawakami, K and Hopkins, N (1996). Highly efficient germ-line transmission of proviral insertions in zebrafish. Proc Natl Acad Sci USA 93: 7777-7782.
31. Chan, AWSE, Homan, J, Ballou, LU, Burns, JC and Bremel, RD (1998). Transgenic cattle produced by reverse-transcribed gene transfer in oocytes. Proc Natl Acad Sci USA 95: 14028-14033.
32. Chan, AWS, Chong, KY, Martinovich, C, Simerly, C and Schatten, G (2001). Transgenic monkeys produced by retroviral gene transfer into mature oocytes. Science 291: 309-312.
33. Hamaguchi, I et al. (2000). Lentivirus vector gene expression during ES cell-derived hematopoietic development in vitro. J Virol 74: 10778-10784.
34. Kustikova, OS et al. (2003). Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population. Blood 102: 3934-3937.
35. Emi, N, Friedmann, T and Yee, JK (1991). Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus. J Virol 65: 1202-1207.